147 related articles for article (PubMed ID: 24452485)
1. Correlation of low expression of hMOF with clinicopathological features of colorectal carcinoma, gastric cancer and renal cell carcinoma.
Cao L; Zhu L; Yang J; Su J; Ni J; Du Y; Liu D; Wang Y; Wang F; Jin J; Cai Y
Int J Oncol; 2014 Apr; 44(4):1207-14. PubMed ID: 24452485
[TBL] [Abstract][Full Text] [Related]
2. Expression of hMOF, but not HDAC4, is responsible for the global histone H4K16 acetylation in gastric carcinoma.
Zhu L; Yang J; Zhao L; Yu X; Wang L; Wang F; Cai Y; Jin J
Int J Oncol; 2015; 46(6):2535-45. PubMed ID: 25873202
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic change in kidney tumor: downregulation of histone acetyltransferase MYST1 in human renal cell carcinoma.
Wang Y; Zhang R; Wu D; Lu Z; Sun W; Cai Y; Wang C; Jin J
J Exp Clin Cancer Res; 2013 Feb; 32(1):8. PubMed ID: 23394073
[TBL] [Abstract][Full Text] [Related]
4. A potential diagnostic marker for ovarian cancer: Involvement of the histone acetyltransferase, human males absent on the first.
Liu N; Zhang R; Zhao X; Su J; Bian X; Ni J; Yue Y; Cai Y; Jin J
Oncol Lett; 2013 Aug; 6(2):393-400. PubMed ID: 24137335
[TBL] [Abstract][Full Text] [Related]
5. The histone acetyltransferase hMOF is frequently downregulated in primary breast carcinoma and medulloblastoma and constitutes a biomarker for clinical outcome in medulloblastoma.
Pfister S; Rea S; Taipale M; Mendrzyk F; Straub B; Ittrich C; Thuerigen O; Sinn HP; Akhtar A; Lichter P
Int J Cancer; 2008 Mar; 122(6):1207-13. PubMed ID: 18058815
[TBL] [Abstract][Full Text] [Related]
6. The histone acetylranseferase hMOF acetylates Nrf2 and regulates anti-drug responses in human non-small cell lung cancer.
Chen Z; Ye X; Tang N; Shen S; Li Z; Niu X; Lu S; Xu L
Br J Pharmacol; 2014 Jul; 171(13):3196-211. PubMed ID: 24571482
[TBL] [Abstract][Full Text] [Related]
7. Role of downregulation of galectin-9 in the tumorigenesis of gastric cancer.
Yang J; Zhu L; Cai Y; Suo J; Jin J
Int J Oncol; 2014 Sep; 45(3):1313-20. PubMed ID: 24919464
[TBL] [Abstract][Full Text] [Related]
8. Opposing effects of hMOF and SIRT1 on H4K16 acetylation and the sensitivity to the topoisomerase II inhibitor etoposide.
Hajji N; Wallenborg K; Vlachos P; Füllgrabe J; Hermanson O; Joseph B
Oncogene; 2010 Apr; 29(15):2192-204. PubMed ID: 20118981
[TBL] [Abstract][Full Text] [Related]
9. Histone acetyltransferase hMOF promotes S phase entry and tumorigenesis in lung cancer.
Zhao L; Wang DL; Liu Y; Chen S; Sun FL
Cell Signal; 2013 Aug; 25(8):1689-98. PubMed ID: 23628702
[TBL] [Abstract][Full Text] [Related]
10. Differential BCCIP gene expression in primary human ovarian cancer, renal cell carcinoma and colorectal cancer tissues.
Liu X; Cao L; Ni J; Liu N; Zhao X; Wang Y; Zhu L; Wang L; Wang J; Yue Y; Cai Y; Jin J
Int J Oncol; 2013 Dec; 43(6):1925-34. PubMed ID: 24101097
[TBL] [Abstract][Full Text] [Related]
11. Capsaicin reactivates hMOF in gastric cancer cells and induces cell growth inhibition.
Wang F; Zhao J; Liu D; Zhao T; Lu Z; Zhu L; Cao L; Yang J; Jin J; Cai Y
Cancer Biol Ther; 2016 Nov; 17(11):1117-1125. PubMed ID: 27715462
[TBL] [Abstract][Full Text] [Related]
12. Expression of hMOF in different ovarian tissues and its effects on ovarian cancer prognosis.
Cai M; Hu Z; Liu J; Gao J; Tan M; Zhang D; Zhu L; Liu S; Hou R; Lin B
Oncol Rep; 2015 Feb; 33(2):685-92. PubMed ID: 25483274
[TBL] [Abstract][Full Text] [Related]
13. The histone acetyltransferase hMOF suppresses hepatocellular carcinoma growth.
Zhang J; Liu H; Pan H; Yang Y; Huang G; Yang Y; Zhou WP; Pan ZY
Biochem Biophys Res Commun; 2014 Sep; 452(3):575-80. PubMed ID: 25181338
[TBL] [Abstract][Full Text] [Related]
14. The histone acetyltransferase hMOF promotes vascular invasion in hepatocellular carcinoma.
Poté N; Cros J; Laouirem S; Raffenne J; Negrão M; Albuquerque M; Bedossa P; Godinho Ferreira M; Ait Si Ali S; Fior R; Paradis V
Liver Int; 2020 Apr; 40(4):956-967. PubMed ID: 31943753
[TBL] [Abstract][Full Text] [Related]
15. hMOF histone acetyltransferase is required for histone H4 lysine 16 acetylation in mammalian cells.
Taipale M; Rea S; Richter K; Vilar A; Lichter P; Imhof A; Akhtar A
Mol Cell Biol; 2005 Aug; 25(15):6798-810. PubMed ID: 16024812
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of glutathione peroxidase 2 in gastric carcinoma.
Liu D; Sun L; Tong J; Chen X; Li H; Zhang Q
Tumour Biol; 2017 Jun; 39(6):1010428317701443. PubMed ID: 28631563
[TBL] [Abstract][Full Text] [Related]
17. Males absent on the first (MOF): from flies to humans.
Rea S; Xouri G; Akhtar A
Oncogene; 2007 Aug; 26(37):5385-94. PubMed ID: 17694080
[TBL] [Abstract][Full Text] [Related]
18. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.
Liu Y; Luo X; Deng J; Pan Y; Zhang L; Liang H
Tumour Biol; 2015 Apr; 36(4):2685-94. PubMed ID: 25472580
[TBL] [Abstract][Full Text] [Related]
19. hMOF (human males absent on the first), an oncogenic protein of human oral tongue squamous cell carcinoma, targeting EZH2 (enhancer of zeste homolog 2).
Li Q; Sun H; Shu Y; Zou X; Zhao Y; Ge C
Cell Prolif; 2015 Aug; 48(4):436-42. PubMed ID: 26032517
[TBL] [Abstract][Full Text] [Related]
20. Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer.
Liu YJ; Yan PS; Li J; Jia JF
World J Gastroenterol; 2005 Nov; 11(42):6601-6. PubMed ID: 16425351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
